FGFR2 and gastric cancer: To verify whether FGFR2 rearrangements can be a marker for targeted therapy in PC GC patients, we transfected TACC2-FGFR2 construct into GC cell lines (MKN45 and NUGC4), which has not been studied in PC GC before.